The healthcare markets worldwide are experiencing significant growth and evolution, primarily driven by an aging population and rising chronic diseases. Global life expectancy has increased by 8 years since 1995(1); already today, 1 out of 3 adults worldwide lives with chronic conditions(2).
Coupled with emerging therapies and technologies such as AI, this places considerable burden on healthcare systems and complex financing challenges. Health spending is expected to reach 10.2% of global GDP by 2030, alongside a global shortage of 10 million healthcare workers in 2030(3). Consequently, healthcare systems are compelled to seek solutions for managing increasing patient volumes and controlling individual treatment costs. This has led to a stronger focus of hospitals on acute diseases and the shift to care outside the hospitals for patients with chronic diseases.
Air Liquide has a unique position in 30 countries, throughout the entire care ecosystem, contributing to meet these challenges. Working with prescribers and healthcare systems and combining human support and digital AI tools to provide “the right level of care at the optimized cost”, we contribute to help physicians focus on their medical mission, and improve patients’ quality of life, thus contributing to building more efficient and resilient healthcare systems.
